Commentary

Spontaneous abortion and antidepressants


 

When we see large studies with large numbers of patients, while exciting, we need to be more critical in interpreting the results, paying attention to the comparison groups and whether the study adjusts for the variables that can be very relevant to the outcome of interest.

Dr. Cohen is the director of the Center for Women’s Mental Health at Massachusetts General Hospital in Boston, which provides information about reproductive mental health at www.womensmentalhealth.org. He has been a consultant to manufacturers of antidepressant medications, and the Danish study was funded with one of the author’s post doc grants from the Danish Council for Independent Research Companies. To comment, e-mail him at obnews@frontlinemedcom.com.

Pages

Recommended Reading

Maternal lupus doubled autism risk
MDedge Psychiatry
SSRI use in pregnancy doesn’t raise autism risk
MDedge Psychiatry
Psychiatric medications and lactation: Informing clinical decisions
MDedge Psychiatry
Luteal-phase antidepressant an option in recalcitrant PMS, PMDD
MDedge Psychiatry
Prenatal acetaminophen exposure may affect ADHD in childhood
MDedge Psychiatry
Treatment decisions complex for pregnant, postpartum women with bipolar disorder
MDedge Psychiatry
Methylphenidate for ADHD in early pregnancy
MDedge Psychiatry
VIDEO: Some SSRIs are better than others for pregnant women
MDedge Psychiatry
More conclusive link needed on teratogenicity and atypicals in pregnancy
MDedge Psychiatry
VIDEO: Overcoming barriers to discussing sexual dysfunction
MDedge Psychiatry